[ 鐧诲綍] [ 鍏嶈垂娉ㄥ唽]
璇曞墏浠櫒缃? title=
浣嶇疆锛欬a href="//www.vuestras.com/sigma-aldrich/">棣栭〉> 鍝佺墝> Sigma-Aldrich> Annexin A1 (MRQ-3) Mouse Monoclonal Antibody

Annexin A1 (MRQ-3) Mouse Monoclonal Antibody

鍝佺墝
Sigma-Aldrich
璐у彿
221M-1
鍖呰鍨嬪彿
瑙勬牸绾害
鍙傝€冧环鏍稽/div>
1956.09 鍏傸/span>*鏈环鏍煎惈澧炲€肩◣璐更/span>
淇冮攢
鏈嶅姟
  • 鈭欬/span>鍘熷巶淇濊瘉
  • 鈭欬/span>鍖呴偖
  • 鈭欬/span>澧炲€肩◣绁?/li>
鏁伴噺
- +
浜у搧鍚嶇О锛欬/div>
Annexin A1 (MRQ-3) Mouse Monoclonal Antibody
浜у搧浠嬬粛锛欬/div>

浜у搧璇存槑

涓€鑸弿杩?/p>

ANXA1 is strongly expressed on the cell membrane and occasionally in the cytoplasm of tumor cells in 97% of samples from patients with hairy cell leukemia. By contrast, B-cell lymphomas other than hairy cell leukemia, including typical splenic lymphoma with villous lymphocytes and patients with variant hairy cell leukemia鈥攁s defined by current morphologic, phenotypic, and clinical criteria鈥攁re ANXA1-negative. In a study by Falini et al. ANXA1 immunodetection was 100% sensitive and specific for hairy cell leukemia. Normal B cells from different lympho-hemopoietic tissues were ANXA1-negative. In this study the expression of ANXA1 in myeloid cells, macrophages, or T-cell subset served as positive control. These findings validated the results of gene expression profiling in hairy cell leukemia at the protein level by showing that ANXA1 is consistently expressed in this type of leukemic disease, but not in other B-cell lymphomas. Of note is that negativity for ANXA1 was also present in patients with splenic lymphoma with villous lymphocytes, variant hairy cell leukemia, prolymphocytic leukemia, marginal zone and lymphoplasmacytoid lymphomas. Thus, ANXA1 is a molecule specific to hairy cell leukemia that can be used to differentiate this disease from other B-cell lymphomas. Wang et al. showed that high ANXA1 expression is frequent in esophageal and esophagogastric junction adenocarcinomas, is associated with more advanced pathologic T stage and the presence of distant metastasis, and is an independent prognostic factor for patient survival.
Associated products: TRAcP, T-bet.

璐ㄩ噺


IVD

IVD

IVD

RUO

鑱旂郴

Annexin A1 Positive Control Slides, Product No. 221S, are available for immunohistochemistry (formalin-fixed, paraffin-embedded sections).

澶栧舰

Solution in Tris Buffer, pH 7.3-7.7, with 1% BSA and <0.1% Sodium Azide

鍒跺璇存槑

Download the IFU specific to your product lot and format
Note: This requires a keycode which can be found on your packaging or product label.

Download the latest released IFU
Note: This IFU may not apply to your specific product lot.

鍏朵粬璇存槑

For Technical Service please contact: 800-665-7284 or email: service@cellmarque.com

娉曞緥淇℃伅

Cell Marque is a trademark of sigma-aldrich Co. LLC

鍩烘湰淇℃伅

NACRES NA.41

浜у搧鎬ц川

璐ㄩ噺姘村钩 500
100
鐢熺墿鏉ユ簮 mouse
鍋惰仈鐗?/td> unconjugated
鎶椾綋褰㈠紡 culture supernatant
antibody product type primary antibodies
鍏嬮殕 MRQ-3, monoclonal
鎻忚堪 For In Vitro Diagnostic Use in Select Regions (See Chart)
褰㈠紡 buffered aqueous solution
species reactivity human
鍖呰 vial of 0.1 mL concentrate (221M-14)
vial of 0.5 mL concentrate (221M-15)
bottle of 1.0 mL predilute (221M-17)
vial of 1.0 mL concentrate (221M-16)
bottle of 7.0 mL predilute (221M-18)
manufacturer/tradename Cell Marque?
technique(s) immunohistochemistry (formalin-fixed, paraffin-embedded sections): 1:100-1:500
鍚屼綅绱?浜氬瀷 IgG1
鎺у埗 hairy cell leukemia
杩愯緭 wet ice
鍌ㄥ瓨娓╁害 2-8鈩傸/td>
鍙鍖朁/td> cytoplasmic, membranous

瀹夊叏淇℃伅

鍌ㄥ瓨鍒嗙被浠g爜 12 - Non Combustible Liquids
WGK WGK 2
闂偣(F) Not applicable
闂偣(C) Not applicable

Sigma-Aldrich

鎺ㄨ崘浜у搧
Baidu
map